⚔️ Head-to-head

Semax vs Selank

Pep lines up the two side by side — verdict, mechanism, and the dimensions that actually differ — so you can see where each one wins.

By MrPepTalks Editorial · Updated 2026-07-08

Semax vs Selank

Semax

Semax acetate · ACTH(4-7) analog

unproven

Selank

TP-7

promising

🏆 Wins on human evidence grade

Semax
Dimension
Selank
A short synthetic peptide derived from a fragment of the ACTH hormone (an ACTH(4-7) analog), with a small tail added so it lasts longer than the natural fragment. Developed in Russia and usually delivered as nasal drops.
What it is
A synthetic peptide derived from tuftsin, a small fragment of a natural immune protein, engineered into a more stable form. Also developed in Russia and most studied as an intranasal preparation.
Leans stimulating and nootropic. Commonly researched for focus, attention, memory, and neuroprotection, largely through a reported effect on brain-derived neurotrophic factor (BDNF).
Main research angle
Leans calming. Commonly researched as an anxiolytic for anxiety, stress, and focus, with a reputation for a non-sedating calm rather than a stimulant-style lift.
Framed as an ACTH-fragment analog acting on neurotrophic signaling; the BDNF story is the mechanism most often cited for its cognitive and neuroprotective interest.
Mechanism (the key difference)
Framed as a tuftsin-derived peptide touching anxiety, immune-signaling, and BDNF-related pathways; the anxiolytic angle is the one with the most human research behind it.
Grade C overall. Much of the supporting work is early-stage, animal, or mechanism-based, plus a regional clinical study in ischaemic stroke; independent English-language randomized trials are few, so the everyday cognitive benefit is not established.
Human evidence grade
Grade B. A small Russian clinical study in generalized anxiety disorder and neurasthenia reported reduced anxiety scores, which gives Selank a human outcome signal that Semax's cognitive claims largely lack.
🏆 winner
The most-cited human work is a Russian study using Semax alongside standard care for ischaemic stroke, which reported functional benefit; the cognitive-enhancement side rests mainly on animal and mechanism data. The trial reported a regional result that has not been widely replicated independently.
What the trials reported
A small Russian trial reported an anxiety-reducing signal broadly comparable to a benzodiazepine comparator, without the sedation seen with that drug in the same study. The trial reported this in a small, narrow population, so it is a signal, not a settled equivalence.
🏆 winner
Commonly reported with the nasal form: nasal irritation or a runny nose, occasional headache, and changes in mood or sleep; some report no noticeable effect. Long-term human safety data outside the Russian literature is thin, so the full profile is not characterized.
Reported side effects
Commonly reported: nasal irritation from the intranasal form, occasional fatigue or lightheadedness, and rarely a paradoxical feeling of unease instead of calm. Because it has not been through large human trials, its side-effect profile is also not well characterized.
Not FDA-approved. Registered as a medicine in Russia, but that status does not carry over; in the United States it is sold for laboratory research use only, not for human use, and has not been proven safe or effective in people.
Regulatory status
Not FDA-approved. Registered and used clinically only in Russia; in the United States it is not approved for any use and is sold for laboratory research use only, and has not been proven safe or effective in people.
If your interest is a stimulating focus or neuroprotection angle, Semax is the one people mean, but go in knowing its human cognitive evidence is the thinner of the two.
Which to read about first
If your interest is a calmer, anxiety-leaning profile, Selank is the better-evidenced pick of the pair thanks to its small human anxiety study, though that evidence is still limited and regional.
🏆 winner
As with any research-grade peptide, the thing that actually varies between vendors is quality control: whether third-party purity and identity testing is published. That is a sourcing question, not an efficacy claim.
Sourcing reality
Same sourcing reality. Gray-market supply can carry contamination, endotoxins, or an identity that does not match the label, and none of that is visible in the vial.
Semax data sheetThe terse reference: facts, forms, and Pep's verdict.Selank data sheetThe terse reference: facts, forms, and Pep's verdict.
Send it to me →

No spam. Compliant with CAN-SPAM (US), CASL (Canada) & GDPR (EU) · one-click unsubscribe. See our Privacy Policy.